FindOwnerSearch
Brands and Their Owners
Welcome to the Brand page for “ARTEMICE”, which is offered here for In the statement, column 1 line 1 artemice should be deleted and artemis should be inserted.;biological as well as biotechnological products, mammals, mammalian cells, dna vectors for transfection of mammalian cells for industrial services within the biotechnology and pharmaceutical industry and for scientific purposes; reagents for scientific or research use, for toxicological and genetic analyses, analyses of genomes and of biological information;scientific and technological services and research and respective designer services, for the generation of mouse models and approaches covering drug discovery, functional gene and genome analysis and production of biological material; research in the fields of biotechnology, pharmaceuticals, diagnostics and toxicology; consulting services in the aforementioned fields for companies in the pharmaceutical industry, doctors and laboratories; toxicological and genetic analyses of genomes and of biological information; genetic engineering services, growing of genetically engineered mutants; licensing of intellectual property and know-how;.
Its status is currently believed to be active. Its class is unavailable. “ARTEMICE” is believed to be currently owned by “TACONICARTEMIS GMBH”.
| Owner: |
TACONICARTEMIS GMBH
Owner Details |
|---|---|
| Description: |
In the statement, Column 1 line 1 ARTEMICE should be deleted and ARTEMIS should be inserted.;Biological as well as biotechnological products, mammals, mammalian cells, DNA vectors for transfection of mammalian cells for industrial services within the biotechnology and pharmaceutical industry and for scientific purposes; reagents for scientific or research use, for toxicological and genetic analyses, analyses of genomes and of biological information;Scientific and technological services and research and respective designer services, for the generation of mouse models and approaches covering drug discovery, functional gene and genome analysis and production of biological material; research in the fields of biotechnology, pharmaceuticals, diagnostics and toxicology; consulting services in the aforementioned fields for companies in the pharmaceutical industry, doctors and laboratories; toxicological and genetic analyses of genomes and of biological information; genetic engineering services, growing of genetically engineered mutants; licensing of intellectual property and know-how;
|
| Categories: | STATEMENT |